Skip to content
★ Sign in to follow
LH

Louis H. Morrone

Vice-Président Senior
Insider activity · 24 months0 buys4 salesCumulative net flow
Total declarations
32
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (10 ops.)
€4.9M

Latest filing published 13 Aug 2026 for Abbott Laboratories, €556k.

Filing timeline

BuySale
Louis H. Morrone

Insider track record

Disclosed buys
0
Disclosed sells
10

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Louis H. Morrone: trading record in brief

This profile gathers the share dealings of Louis H. Morrone in Abbott Laboratories, where the filings describe the role as senior executive. In total, 32 filings cover trades dated from 1 July 2021 to 12 August 2026.

Every open-market trade on record is a sale: 10 sales worth €4.9M. Besides market trades, the filings include 18 share grants and 3 option exercises. 2026 to date brings no purchases and 2 sales.

The latest filing, published on 13 August 2026, reports an open-market sale of €556k in Abbott Laboratories. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Louis H. Morrone

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations24 total
  • ▼
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    642,506 USD13SEC
    5,850 shares@ US$109.830.0003% mcap14.0% of flowCommon shares without par valueSEC:0001867666-26-000013:0
  • ●
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    1,296 USD12SEC
    12 shares@ US$107.990.0000% mcap0.0% of flowCommon shares without par valueSEC:0001867666-26-000013:1
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    0SEC
    269 sharesCommon shares without par valueSEC:0001867666-26-000009:0
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    469,690 USD19SEC
    4,040 shares@ US$116.269.3% of flowCommon shares without par valueSEC:0001867666-26-000007:0
  • ▼
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    132,224 USD36SEC
    1,144 shares@ US$115.582.6% of flowCommon shares without par valueSEC:0001867666-26-000007:1
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    0SEC
    15,418 shares0Common shares without par valueSEC:0001867666-26-000002:0
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    36,148 USD18SEC
    269 shares@ US$134.380.7% of flowCommon shares without par valueSEC:0001415889-25-018725:0
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    595,926 USD19SEC
    4,386 shares@ US$135.8713.5% of flowCommon shares without par valueSEC:0001415889-25-006788:0
  • ▼
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    153,507 USD36SEC
    1,111 shares@ US$138.173.5% of flowCommon shares without par valueSEC:0001415889-25-006788:1
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    0SEC
    10,232 shares0Common shares without par valueSEC:0001415889-25-005900:0
  • ▼
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    336,819 USD19SEC
    2,644 shares@ US$127.397.6% of flowCommon shares without par valueSEC:0001415889-25-002423:0
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    27,952 USD18SEC
    269 shares@ US$103.910.6% of flowCommon shares without par valueSEC:0001415889-24-018920:0
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    57,774 USD18SEC
    556 shares@ US$103.911.3% of flowCommon shares without par valueSEC:0001415889-24-018920:1
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    414,773 USD19SEC
    3,455 shares@ US$120.059.0% of flowCommon shares without par valueSEC:0001415889-24-006413:0
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    0SEC
    12,309 shares0Common shares without par valueSEC:0001415889-24-005107:0
  • ◆
    EXECUTIVE VICE PRESIDENTExecutivesAbbott Laboratories
    0SEC
    1,815 shares0Common shares without par valueSEC:0001104659-23-077919:0
  • ◆
    SENIOR VICE PRESIDENTExecutivesAbbott Laboratories
    252,817 USD19SEC
    2,534 shares@ US$99.775.6% of flowCommon shares without par valueSEC:0001415889-23-003913:0
  • ◆
    SENIOR VICE PRESIDENTExecutivesAbbott Laboratories
    0SEC
    10,560 shares0Common shares without par valueSEC:0001415889-23-003058:0
  • ◆
    SENIOR VICE PRESIDENTExecutivesAbbott Laboratories
    60,409 USD22SEC
    556 shares@ US$108.650.0000% mcap2.9% of flowCommon shares without par valueSEC:0001415889-22-007182:0
  • ◆
    SENIOR VICE PRESIDENTExecutivesAbbott Laboratories
    237,720 USD12SEC
    1,942 shares@ US$122.416.2% of flowCommon shares without par valueSEC:0001415889-22-002198:0
  • ◆
    SENIOR VICE PRESIDENTExecutivesAbbott Laboratories
    0SEC
    11,647 shares0Common shares without par valueSEC:0001415889-22-001743:0
  • ◇
    SENIOR VICE PRESIDENTExecutivesAbbott Laboratories
    482,820 USD12SEC
    9,988 shares@ US$48.3412.5% of flowCommon shares without par valueSEC:0001415889-21-006162:0
  • ◇
    SENIOR VICE PRESIDENTExecutivesAbbott Laboratories
    482,868 USD12SEC
    9,989 shares@ US$48.3412.5% of flowCommon shares without par valueSEC:0001415889-21-005787:0
  • ◆
    SENIOR VICE PRESIDENTExecutivesAbbott Laboratories
    0SEC
    3,764 shares0Common shares without par valueSEC:0001415889-21-003513:0

24 of 24 declarations